FY24 Funding, HHS
HELP Copays Act
Safe Step Act
Duration: January 29, 2015
to
February 1, 2023
General Issues: Budget/Appropriations , Health Issues
Spending: about $310,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2015: U.S. Senate, House of Representatives, Natl Institutes of Health (NIH), Centers For Disease Control & Prevention (CDC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2023
Health and Medicine Counsel, LLC terminated an engagement in which they represented American Liver Foundation on April 6, 2023.
Original Filing: 301449293.xml
Agencies Lobbied
U.S. Senate
Lobbying Issues
HELP Copays Act
Safe Step Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Health and Medicine Counsel, LLC lobbied for American Liver Foundation , earning $10,000. The report was filed on Jan. 1, 2023.
Original Filing: 301424383.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY22
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY22
House/Senate Defense Appropriations bill, FY22
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Step Therapy Legislation
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Health and Medicine Counsel, LLC lobbied for American Liver Foundation , earning $10,000. The report was filed on Oct. 5, 2022.
Original Filing: 301401381.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY22
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY22
House/Senate Defense Appropriations bill, FY22
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Step Therapy Legislation
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Health and Medicine Counsel, LLC lobbied for American Liver Foundation , earning $10,000. The report was filed on July 12, 2022.
Original Filing: 301378968.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY22
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY22
House/Senate Defense Appropriations bill, FY22
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Step Therapy Legislation
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Health and Medicine Counsel, LLC lobbied for American Liver Foundation , earning $10,000. The report was filed on April 14, 2022.
Original Filing: 301356157.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY22
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY22
House/Senate Defense Appropriations bill, FY22
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Step Therapy Legislation
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Health and Medicine Counsel, LLC lobbied for American Liver Foundation , earning $10,000. The report was filed on Jan. 14, 2022.
Original Filing: 301322412.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY22
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY22
House/Senate Defense Appropriations bill, FY22
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Step Therapy Legislation
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Oct. 4, 2021.
Original Filing: 301296421.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY22
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY22
House/Senate Defense Appropriations bill, FY22
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Step Therapy Legislation
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on July 7, 2021.
Original Filing: 301273867.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY22
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY22
House/Senate Defense Appropriations bill, FY22
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
COVID-19 Relief Packages
Step Therapy Legislation
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on April 7, 2021.
Original Filing: 301251090.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY22
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY22
House/Senate Defense Appropriations bill, FY22
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
COVID-19 Relief Packages
Step Therapy Legislation
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Jan. 13, 2021.
Original Filing: 301230335.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY21
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY21
House/Senate Defense Appropriations bill, FY21
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
LIVER Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Oct. 8, 2020.
Original Filing: 301208062.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY21
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY21
House/Senate Defense Appropriations bill, FY21
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
LIVER Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on July 7, 2020.
Original Filing: 301185594.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY20
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY20
House/Senate Defense Appropriations bill, FY20
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
LIVER Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on April 9, 2020.
Original Filing: 301154933.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY20
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY20
House/Senate Defense Appropriations bill, FY20
COVID-19 Supplemental Appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
LIVER Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
COVID-19 Relief Packages
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Jan. 15, 2020.
Original Filing: 301105773.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY20
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY20
House/Senate Defense Appropriations bill, FY20
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
LIVER Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Oct. 4, 2019.
Original Filing: 301063283.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY20
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY20
House/Senate Defense Appropriations bill, FY20
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
LIVER Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on July 9, 2019.
Original Filing: 301043763.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY20
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY20
House/Senate Defense Appropriations bill, FY20
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
LIVER Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on April 11, 2019.
Original Filing: 301024247.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill, FY20
NIH funding for liver disease research & liver cancer
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill, FY20
House/Senate Defense Appropriations bill, FY20
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for Liver Diseases at NIDDK & Liver Cancer & NKI
CDC Division of Viral Hepatitis funding, liver cancer funding
LIVER Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation legislation
CDC's elimination initiative
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Jan. 7, 2019.
Original Filing: 301002440.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
LIVER Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Oct. 10, 2018.
Original Filing: 300983992.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on July 11, 2018.
Original Filing: 300963551.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
HEALTH AND MEDICINE COUNSEL OF WASHINGTON amended a lobbying report for representation of American Liver Foundation in Q22018 on July 11, 2018.
Original Filing: 300963553.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
VA HCV Testing Policy
Organ donation/transplantation
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on April 11, 2018.
Original Filing: 300943627.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Access to Marketplace Insurance Act
Opioid & Infectious Disease Programs
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Jan. 10, 2018.
Original Filing: 300922310.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Oct. 6, 2017.
Original Filing: 300901705.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on July 12, 2017.
Original Filing: 300883789.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on April 11, 2017.
Original Filing: 300863894.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Jan. 19, 2017.
Original Filing: 300850668.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Oct. 14, 2016.
Original Filing: 300827889.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on July 19, 2016.
Original Filing: 300813668.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on April 6, 2016.
Original Filing: 300788604.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Jan. 19, 2016.
Original Filing: 300776170.xml
Lobbying Issues
House & Senate L-HHS Appropriations bill
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
House/Senate MilCon-VA Appropriations bill
House/Senate Defense Appropriations bill
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation , earning $10,000. The report was filed on Oct. 14, 2015.
Original Filing: 300752845.xml
Lobbying Issues
House & Senate L-HHS Appropriations
NIH funding for liver disease research
CDC, Division of Viral Hepatitis funding
Dept. of VA, liver & viral hepatitis research
Dept. of Defense, liver cancer research funding
Viral Hepatitis Testing Act
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC Division of Viral Hepatitis funding
Viral Hepatitis Testing Act
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation . The report was filed on July 10, 2015.
Original Filing: 300733050.xml
Lobbying Issues
House & Senate L-HHS Appropriations
NIH funding
CDC, Division of Viral Hepatitis funding
Dept. of VA, liver & viral hepatitis research
Dept. of Defense, liver cancer research funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC's Division of Viral Hepatitis
Education and Awareness of liver diseases, liver cancer, hepatitis B & C
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, HEALTH AND MEDICINE COUNSEL OF WASHINGTON lobbied for American Liver Foundation . The report was filed on April 14, 2015.
Original Filing: 300715284.xml
Lobbying Issues
LHHS
Defense
Veterans Affairs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC's Division of Viral Hepatitis
Education and Awareness of liver diseases, liver cancer, hepatitis B & C
Patients Access to Treatments Act
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
Health and Medicine Counsel of Washington filed a lobbying registration on April 13, 2015 to represent American Liver Foundation, effective Jan. 29, 2015.
Original Filing: 300714644.xml
Issue(s) they said they’d lobby about: BUD:
LHHS
Defense
Veterans Affairs
HCR:
Research funding for the Liver Diseases Branch of the NIDDK at NIH
CDC's Division of Viral Hepatitis
Education & Awareness of liver diseases, liver cancer, hepatitis B & C
Patients Access to Treatments Act .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...